Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer
A Phase I Study of Entinostat in Combination With Enzalutamide for Treatment of Patients With Castration-Resistant Prostate Cancer
Sponsor: George Washington University
Terminated
Sponsor discontinued the drug
Other terminated trials from George Washington University
Other Prostate Adenocarcinoma trials with similar outcome
A PHASE1 clinical study on Prostate Adenocarcinoma, this trial is terminated or withdrawn. The trial is conducted by George Washington University and has accumulated 8 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Sep 2021 — Jul 2024 [monthly]
Terminated PHASE1
Status: Recruiting → Terminated
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE1
▶ Show 3 earlier versions
-
Sep 2019 — Jan 2021 [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
May 2019 — Sep 2019 [monthly]
Not Yet Recruiting PHASE1
-
Mar 2019 — May 2019 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- George Washington University
For direct contact, visit the study record on ClinicalTrials.gov .